COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
Chiara SciroccoSara FerrignoLaura AndreoliMicaela FrediClaudia LomaterLuca MoroniMarta MoscaBernd RaffeinerGreta CarraraGianpiero LandolfiDavide RozzaAnna ZanettiAnd Carlo Alberto ScirèGian Domenico SebastianiPublished in: Lupus science & medicine (2023)
Our data suggest that patients with SLE and RA do not show a different COVID-19 outcome, while patients with SPA have a more favourable disease course compared with those with SLE. Risk of hospitalisation with ventilation or death was associated with age >65 years, hypertension and PDN use in patients with SLE.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- coronavirus disease
- juvenile idiopathic arthritis
- ankylosing spondylitis
- sars cov
- blood pressure
- interstitial lung disease
- electronic health record
- respiratory syndrome coronavirus
- big data
- respiratory failure
- artificial intelligence
- mechanical ventilation
- idiopathic pulmonary fibrosis